img

Global Adalimumab Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Adalimumab Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Adalimumab Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Adalimumab Injection market is projected to reach US$ 1324.3 million in 2029, increasing from US$ 910 million in 2022, with the CAGR of 5.6% during the period of 2024 to 2029. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Adalimumab Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Adalimumab Injection key manufacturers include AbbVie, Amgen, Sandoz, Fresenius Kabi, Biogen, Celltrion, Cadila Pharmaceuticals, Bio-Thera Solutions, Ltd. and Hisun Biopharmaceutical, etc. AbbVie, Amgen, Sandoz are top 3 players and held % sales share in total in 2022.
Adalimumab Injection can be divided into 40mg/0.8ml and 20mg/0.4ml, etc. 40mg/0.8ml is the mainstream product in the market, accounting for % sales share globally in 2022.
Adalimumab Injection is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Adalimumab Injection industry development. In 2022, global % sales of Adalimumab Injection went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Adalimumab Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AbbVie
Amgen
Sandoz
Fresenius Kabi
Biogen
Celltrion
Cadila Pharmaceuticals
Bio-Thera Solutions, Ltd.
Hisun Biopharmaceutical
Innovent Biologics
Mylan
Zydus Group
Boehringer Ingelheim
Jiangsu Chia Tai-Tianqing Pharmaceutical
Shanghai Henlius Biotech
Segment by Type
40mg/0.8ml
20mg/0.4ml

Segment by Application


Hospitals
Clinics
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Adalimumab Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Adalimumab Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Adalimumab Injection industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Adalimumab Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Adalimumab Injection introduction, etc. Adalimumab Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Adalimumab Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Adalimumab Injection Market Overview
1.1 Adalimumab Injection Product Overview
1.2 Adalimumab Injection Market Segment by Type
1.2.1 40mg/0.8ml
1.2.2 20mg/0.4ml
1.3 Global Adalimumab Injection Market Size by Type
1.3.1 Global Adalimumab Injection Market Size Overview by Type (2018-2029)
1.3.2 Global Adalimumab Injection Historic Market Size Review by Type (2018-2024)
1.3.3 Global Adalimumab Injection Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Adalimumab Injection Sales Breakdown by Type (2018-2024)
1.4.2 Europe Adalimumab Injection Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Adalimumab Injection Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Adalimumab Injection Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Adalimumab Injection Sales Breakdown by Type (2018-2024)
2 Global Adalimumab Injection Market Competition by Company
2.1 Global Top Players by Adalimumab Injection Sales (2018-2024)
2.2 Global Top Players by Adalimumab Injection Revenue (2018-2024)
2.3 Global Top Players by Adalimumab Injection Price (2018-2024)
2.4 Global Top Manufacturers Adalimumab Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Adalimumab Injection Market Competitive Situation and Trends
2.5.1 Adalimumab Injection Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Adalimumab Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Adalimumab Injection as of 2022)
2.7 Date of Key Manufacturers Enter into Adalimumab Injection Market
2.8 Key Manufacturers Adalimumab Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Adalimumab Injection Status and Outlook by Region
3.1 Global Adalimumab Injection Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Adalimumab Injection Historic Market Size by Region
3.2.1 Global Adalimumab Injection Sales in Volume by Region (2018-2024)
3.2.2 Global Adalimumab Injection Sales in Value by Region (2018-2024)
3.2.3 Global Adalimumab Injection Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Adalimumab Injection Forecasted Market Size by Region
3.3.1 Global Adalimumab Injection Sales in Volume by Region (2024-2029)
3.3.2 Global Adalimumab Injection Sales in Value by Region (2024-2029)
3.3.3 Global Adalimumab Injection Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Adalimumab Injection by Application
4.1 Adalimumab Injection Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Adalimumab Injection Market Size by Application
4.2.1 Global Adalimumab Injection Market Size Overview by Application (2018-2029)
4.2.2 Global Adalimumab Injection Historic Market Size Review by Application (2018-2024)
4.2.3 Global Adalimumab Injection Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Adalimumab Injection Sales Breakdown by Application (2018-2024)
4.3.2 Europe Adalimumab Injection Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Adalimumab Injection Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Adalimumab Injection Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Adalimumab Injection Sales Breakdown by Application (2018-2024)
5 North America Adalimumab Injection by Country
5.1 North America Adalimumab Injection Historic Market Size by Country
5.1.1 North America Adalimumab Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Adalimumab Injection Sales in Volume by Country (2018-2024)
5.1.3 North America Adalimumab Injection Sales in Value by Country (2018-2024)
5.2 North America Adalimumab Injection Forecasted Market Size by Country
5.2.1 North America Adalimumab Injection Sales in Volume by Country (2024-2029)
5.2.2 North America Adalimumab Injection Sales in Value by Country (2024-2029)
6 Europe Adalimumab Injection by Country
6.1 Europe Adalimumab Injection Historic Market Size by Country
6.1.1 Europe Adalimumab Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Adalimumab Injection Sales in Volume by Country (2018-2024)
6.1.3 Europe Adalimumab Injection Sales in Value by Country (2018-2024)
6.2 Europe Adalimumab Injection Forecasted Market Size by Country
6.2.1 Europe Adalimumab Injection Sales in Volume by Country (2024-2029)
6.2.2 Europe Adalimumab Injection Sales in Value by Country (2024-2029)
7 Asia-Pacific Adalimumab Injection by Region
7.1 Asia-Pacific Adalimumab Injection Historic Market Size by Region
7.1.1 Asia-Pacific Adalimumab Injection Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Adalimumab Injection Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Adalimumab Injection Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Adalimumab Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Adalimumab Injection Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Adalimumab Injection Sales in Value by Region (2024-2029)
8 Latin America Adalimumab Injection by Country
8.1 Latin America Adalimumab Injection Historic Market Size by Country
8.1.1 Latin America Adalimumab Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Adalimumab Injection Sales in Volume by Country (2018-2024)
8.1.3 Latin America Adalimumab Injection Sales in Value by Country (2018-2024)
8.2 Latin America Adalimumab Injection Forecasted Market Size by Country
8.2.1 Latin America Adalimumab Injection Sales in Volume by Country (2024-2029)
8.2.2 Latin America Adalimumab Injection Sales in Value by Country (2024-2029)
9 Middle East and Africa Adalimumab Injection by Country
9.1 Middle East and Africa Adalimumab Injection Historic Market Size by Country
9.1.1 Middle East and Africa Adalimumab Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Adalimumab Injection Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Adalimumab Injection Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Adalimumab Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Adalimumab Injection Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Adalimumab Injection Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AbbVie
10.1.1 AbbVie Company Information
10.1.2 AbbVie Introduction and Business Overview
10.1.3 AbbVie Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
10.1.4 AbbVie Adalimumab Injection Products Offered
10.1.5 AbbVie Recent Development
10.2 Amgen
10.2.1 Amgen Company Information
10.2.2 Amgen Introduction and Business Overview
10.2.3 Amgen Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Amgen Adalimumab Injection Products Offered
10.2.5 Amgen Recent Development
10.3 Sandoz
10.3.1 Sandoz Company Information
10.3.2 Sandoz Introduction and Business Overview
10.3.3 Sandoz Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sandoz Adalimumab Injection Products Offered
10.3.5 Sandoz Recent Development
10.4 Fresenius Kabi
10.4.1 Fresenius Kabi Company Information
10.4.2 Fresenius Kabi Introduction and Business Overview
10.4.3 Fresenius Kabi Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Fresenius Kabi Adalimumab Injection Products Offered
10.4.5 Fresenius Kabi Recent Development
10.5 Biogen
10.5.1 Biogen Company Information
10.5.2 Biogen Introduction and Business Overview
10.5.3 Biogen Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Biogen Adalimumab Injection Products Offered
10.5.5 Biogen Recent Development
10.6 Celltrion
10.6.1 Celltrion Company Information
10.6.2 Celltrion Introduction and Business Overview
10.6.3 Celltrion Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Celltrion Adalimumab Injection Products Offered
10.6.5 Celltrion Recent Development
10.7 Cadila Pharmaceuticals
10.7.1 Cadila Pharmaceuticals Company Information
10.7.2 Cadila Pharmaceuticals Introduction and Business Overview
10.7.3 Cadila Pharmaceuticals Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Cadila Pharmaceuticals Adalimumab Injection Products Offered
10.7.5 Cadila Pharmaceuticals Recent Development
10.8 Bio-Thera Solutions, Ltd.
10.8.1 Bio-Thera Solutions, Ltd. Company Information
10.8.2 Bio-Thera Solutions, Ltd. Introduction and Business Overview
10.8.3 Bio-Thera Solutions, Ltd. Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bio-Thera Solutions, Ltd. Adalimumab Injection Products Offered
10.8.5 Bio-Thera Solutions, Ltd. Recent Development
10.9 Hisun Biopharmaceutical
10.9.1 Hisun Biopharmaceutical Company Information
10.9.2 Hisun Biopharmaceutical Introduction and Business Overview
10.9.3 Hisun Biopharmaceutical Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Hisun Biopharmaceutical Adalimumab Injection Products Offered
10.9.5 Hisun Biopharmaceutical Recent Development
10.10 Innovent Biologics
10.10.1 Innovent Biologics Company Information
10.10.2 Innovent Biologics Introduction and Business Overview
10.10.3 Innovent Biologics Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Innovent Biologics Adalimumab Injection Products Offered
10.10.5 Innovent Biologics Recent Development
10.11 Mylan
10.11.1 Mylan Company Information
10.11.2 Mylan Introduction and Business Overview
10.11.3 Mylan Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Mylan Adalimumab Injection Products Offered
10.11.5 Mylan Recent Development
10.12 Zydus Group
10.12.1 Zydus Group Company Information
10.12.2 Zydus Group Introduction and Business Overview
10.12.3 Zydus Group Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Zydus Group Adalimumab Injection Products Offered
10.12.5 Zydus Group Recent Development
10.13 Boehringer Ingelheim
10.13.1 Boehringer Ingelheim Company Information
10.13.2 Boehringer Ingelheim Introduction and Business Overview
10.13.3 Boehringer Ingelheim Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Boehringer Ingelheim Adalimumab Injection Products Offered
10.13.5 Boehringer Ingelheim Recent Development
10.14 Jiangsu Chia Tai-Tianqing Pharmaceutical
10.14.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Company Information
10.14.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Introduction and Business Overview
10.14.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Products Offered
10.14.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Development
10.15 Shanghai Henlius Biotech
10.15.1 Shanghai Henlius Biotech Company Information
10.15.2 Shanghai Henlius Biotech Introduction and Business Overview
10.15.3 Shanghai Henlius Biotech Adalimumab Injection Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Shanghai Henlius Biotech Adalimumab Injection Products Offered
10.15.5 Shanghai Henlius Biotech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Adalimumab Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Adalimumab Injection Industrial Chain Analysis
11.4 Adalimumab Injection Market Dynamics
11.4.1 Adalimumab Injection Industry Trends
11.4.2 Adalimumab Injection Market Drivers
11.4.3 Adalimumab Injection Market Challenges
11.4.4 Adalimumab Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Adalimumab Injection Distributors
12.3 Adalimumab Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 40mg/0.8ml
Table 2. Major Company of 20mg/0.4ml
Table 3. Global Adalimumab Injection Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Adalimumab Injection Sales by Type (2018-2024) & (K Units)
Table 5. Global Adalimumab Injection Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Adalimumab Injection Sales by Type (2018-2024) & (US& Million)
Table 7. Global Adalimumab Injection Market Share in Value by Type (2018-2024)
Table 8. Global Adalimumab Injection Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Adalimumab Injection Sales by Type (2024-2029) & (K Units)
Table 10. Global Adalimumab Injection Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Adalimumab Injection Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Adalimumab Injection Sales Market Share in Value by Type (2024-2029)
Table 13. Global Adalimumab Injection Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Adalimumab Injection Sales by Type (2018-2024) & (K Units)
Table 15. North America Adalimumab Injection Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Adalimumab Injection Sales (K Units) by Type (2018-2024)
Table 17. Europe Adalimumab Injection Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Adalimumab Injection Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Adalimumab Injection Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Adalimumab Injection Sales (K Units) by Type (2018-2024)
Table 21. Latin America Adalimumab Injection Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Adalimumab Injection Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Adalimumab Injection Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Adalimumab Injection Sales by Company (2018-2024) & (K Units)
Table 25. Global Adalimumab Injection Sales Share by Company (2018-2024)
Table 26. Global Adalimumab Injection Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Adalimumab Injection Revenue Share by Company (2018-2024)
Table 28. Global Market Adalimumab Injection Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Adalimumab Injection Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Adalimumab Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Adalimumab Injection as of 2022)
Table 32. Date of Key Manufacturers Enter into Adalimumab Injection Market
Table 33. Key Manufacturers Adalimumab Injection Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Adalimumab Injection Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Adalimumab Injection Sales by Region (2018-2024) & (K Units)
Table 37. Global Adalimumab Injection Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Adalimumab Injection Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Adalimumab Injection Sales Market Share in Value by Region (2018-2024)
Table 40. Global Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Adalimumab Injection Sales by Region (2024-2029) & (K Units)
Table 42. Global Adalimumab Injection Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Adalimumab Injection Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Adalimumab Injection Sales Market Share in Value by Region (2024-2029)
Table 45. Global Adalimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Adalimumab Injection Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Adalimumab Injection Sales by Application (2018-2024) & (K Units)
Table 48. Global Adalimumab Injection Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Adalimumab Injection Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Adalimumab Injection Sales Market Share in Value by Application (2018-2024)
Table 51. Global Adalimumab Injection Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Adalimumab Injection Sales by Application (2024-2029) & (K Units)
Table 53. Global Adalimumab Injection Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Adalimumab Injection Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Adalimumab Injection Sales Market Share in Value by Application (2024-2029)
Table 56. Global Adalimumab Injection Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Adalimumab Injection Sales by Application (2018-2024) (K Units)
Table 58. North America Adalimumab Injection Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Adalimumab Injection Sales by Application (2018-2024) (K Units)
Table 60. Europe Adalimumab Injection Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Adalimumab Injection Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Adalimumab Injection Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Adalimumab Injection Sales by Application (2018-2024) (K Units)
Table 64. Latin America Adalimumab Injection Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Adalimumab Injection Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Adalimumab Injection Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Adalimumab Injection Sales by Country (2018-2024) & (K Units)
Table 68. North America Adalimumab Injection Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Adalimumab Injection Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Adalimumab Injection Sales Market Share in Value by Country (2018-2024)
Table 71. North America Adalimumab Injection Sales by Country (2024-2029) & (K Units)
Table 72. North America Adalimumab Injection Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Adalimumab Injection Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Adalimumab Injection Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Adalimumab Injection Sales by Country (2018-2024) & (K Units)
Table 76. Europe Adalimumab Injection Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Adalimumab Injection Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Adalimumab Injection Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Adalimumab Injection Sales by Country (2024-2029) & (K Units)
Table 80. Europe Adalimumab Injection Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Adalimumab Injection Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Adalimumab Injection Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Adalimumab Injection Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Adalimumab Injection Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Adalimumab Injection Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Adalimumab Injection Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Adalimumab Injection Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Adalimumab Injection Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Adalimumab Injection Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Adalimumab Injection Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Adalimumab Injection Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Adalimumab Injection Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Adalimumab Injection Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Adalimumab Injection Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Adalimumab Injection Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Adalimumab Injection Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Adalimumab Injection Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Adalimumab Injection Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Adalimumab Injection Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Adalimumab Injection Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Adalimumab Injection Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Adalimumab Injection Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Adalimumab Injection Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Adalimumab Injection Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Adalimumab Injection Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Adalimumab Injection Sales Market Share in Value by Country (2024-2029)
Table 107. AbbVie Company Information
Table 108. AbbVie Introduction and Business Overview
Table 109. AbbVie Adalimumab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. AbbVie Adalimumab Injection Product
Table 111. AbbVie Recent Development
Table 112. Amgen Company Information
Table 113. Amgen Introduction and Business Overview
Table 114. Amgen Adalimumab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Amgen Adalimumab Injection Product
Table 116. Amgen Recent Development
Table 117. Sandoz Company Information
Table 118. Sandoz Introduction and Business Overview
Table 119. Sandoz Adalimumab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Sandoz Adalimumab Injection Product
Table 121. Sandoz Recent Development
Table 122. Fresenius Kabi Company Information
Table 123. Fresenius Kabi Introduction and Business Overview
Table 124. Fresenius Kabi Adalimumab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Fresenius Kabi Adalimumab Injection Product
Table 126. Fresenius Kabi Recent Development
Table 127. Biogen Company Information
Table 128. Biogen Introduction and Business Overview
Table 129. Biogen Adalimumab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Biogen Adalimumab Injection Product
Table 131. Biogen Recent Development
Table 132. Celltrion Company Information
Table 133. Celltrion Introduction and Business Overview
Table 134. Celltrion Adalimumab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Celltrion Adalimumab Injection Product
Table 136. Celltrion Recent Development
Table 137. Cadila Pharmaceuticals Company Information
Table 138. Cadila Pharmaceuticals Introduction and Business Overview
Table 139. Cadila Pharmaceuticals Adalimumab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Cadila Pharmaceuticals Adalimumab Injection Product
Table 141. Cadila Pharmaceuticals Recent Development
Table 142. Bio-Thera Solutions, Ltd. Company Information
Table 143. Bio-Thera Solutions, Ltd. Introduction and Business Overview
Table 144. Bio-Thera Solutions, Ltd. Adalimumab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Bio-Thera Solutions, Ltd. Adalimumab Injection Product
Table 146. Bio-Thera Solutions, Ltd. Recent Development
Table 147. Hisun Biopharmaceutical Company Information
Table 148. Hisun Biopharmaceutical Introduction and Business Overview
Table 149. Hisun Biopharmaceutical Adalimumab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Hisun Biopharmaceutical Adalimumab Injection Product
Table 151. Hisun Biopharmaceutical Recent Development
Table 152. Innovent Biologics Company Information
Table 153. Innovent Biologics Introduction and Business Overview
Table 154. Innovent Biologics Adalimumab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Innovent Biologics Adalimumab Injection Product
Table 156. Innovent Biologics Recent Development
Table 157. Mylan Company Information
Table 158. Mylan Introduction and Business Overview
Table 159. Mylan Adalimumab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Mylan Adalimumab Injection Product
Table 161. Mylan Recent Development
Table 162. Zydus Group Company Information
Table 163. Zydus Group Introduction and Business Overview
Table 164. Zydus Group Adalimumab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Zydus Group Adalimumab Injection Product
Table 166. Zydus Group Recent Development
Table 167. Boehringer Ingelheim Company Information
Table 168. Boehringer Ingelheim Introduction and Business Overview
Table 169. Boehringer Ingelheim Adalimumab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Boehringer Ingelheim Adalimumab Injection Product
Table 171. Boehringer Ingelheim Recent Development
Table 172. Jiangsu Chia Tai-Tianqing Pharmaceutical Company Information
Table 173. Jiangsu Chia Tai-Tianqing Pharmaceutical Introduction and Business Overview
Table 174. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product
Table 176. Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Development
Table 177. Shanghai Henlius Biotech Company Information
Table 178. Shanghai Henlius Biotech Introduction and Business Overview
Table 179. Shanghai Henlius Biotech Adalimumab Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Shanghai Henlius Biotech Adalimumab Injection Product
Table 181. Shanghai Henlius Biotech Recent Development
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Adalimumab Injection Market Trends
Table 185. Adalimumab Injection Market Drivers
Table 186. Adalimumab Injection Market Challenges
Table 187. Adalimumab Injection Market Restraints
Table 188. Adalimumab Injection Distributors List
Table 189. Adalimumab Injection Downstream Customers
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Adalimumab Injection Product Picture
Figure 2. Global Adalimumab Injection Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Adalimumab Injection Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Adalimumab Injection Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of 40mg/0.8ml
Figure 6. Global 40mg/0.8ml Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of 20mg/0.4ml
Figure 8. Global 20mg/0.4ml Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Adalimumab Injection Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Adalimumab Injection Sales Market Share by Type in 2022 & 2029
Figure 11. North America Adalimumab Injection Sales Market Share in Volume by Type in 2022
Figure 12. North America Adalimumab Injection Sales Market Share in Value by Type in 2022
Figure 13. Europe Adalimumab Injection Sales Market Share in Volume by Type in 2022
Figure 14. Europe Adalimumab Injection Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Adalimumab Injection Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Adalimumab Injection Sales Market Share in Value by Type in 2022
Figure 17. Latin America Adalimumab Injection Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Adalimumab Injection Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Adalimumab Injection Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Adalimumab Injection Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Adalimumab Injection Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Adalimumab Injection Revenue in 2022
Figure 23. Adalimumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospitals
Figure 25. Global Hospitals Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Clinics
Figure 27. Global Clinics Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Global Adalimumab Injection Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Adalimumab Injection Sales Market Share by Application in 2022 & 2029
Figure 32. North America Adalimumab Injection Sales Market Share in Volume by Application in 2022
Figure 33. North America Adalimumab Injection Sales Market Share in Value by Application in 2022
Figure 34. Europe Adalimumab Injection Sales Market Share in Volume by Application in 2022
Figure 35. Europe Adalimumab Injection Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Adalimumab Injection Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Adalimumab Injection Sales Market Share in Value by Application in 2022
Figure 38. Latin America Adalimumab Injection Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Adalimumab Injection Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Adalimumab Injection Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Adalimumab Injection Manufacturing Cost Structure
Figure 43. Adalimumab Injection Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries